PD-1 blockade therapy enhances the antitumor effects of lymphodepletion and adoptive T cell transfer

被引：0
|
作者：
Watanabe, Satoshi
Takahashi, Miho
Suzuki, Ryo
Arita, Masashi
Sato, Ko
Fujisaki, Toshiya
Ohtsubo, Aya
Shoji, Satoshi
Shono, Kunihiro
Masuda, Takaaki
Sekiya, Tomoki
Nozaki, Koichiro
Tanaka, Tomohiro
Kondo, Rie
Saida, Yu
Hokari, Satoshi
Koya, Toshiyuki
Kikuchi, Toshiaki
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4064
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4064
引用
收藏
页数：2
相关论文
共 50 条
  • [31] OX40 enhances T cell immune response to PD-1 blockade therapy in non-small cell lung cancer
    Lao, Juanfeng
    Cao, Can
    Niu, Xiaoli
    Deng, Simei
    Ming, Siqi
    Liang, Siping
    Shang, Yuqi
    Yuan, Yulin
    Shi, Xiaomin
    Liang, Zibin
    Wu, Minhao
    Wu, Yongjian
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 108
  • [32] TRIPLE CHECKPOINT BLOCKADE, BUT NOT ANTI-PD1 ALONE, ENHANCES THE EFFICACY OF ENGINEERED ADOPTIVE T CELL THERAPY IN ADVANCED OVARIAN CANCER
    Anderson, Kristin
    Su, Yapeng
    Burnett, Madison
    Bates, Breanna
    Suarez, Magdalia Rodgers
    Ruskin, Susan
    Vakil, Aesha
    Voillet, Valentin
    Gottardo, Raphael
    Greenberg, Philip
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A590 - A590
  • [33] Combined antitumor effects of anti-EGFR variant III CAR-T cell therapy and PD-1 checkpoint blockade on glioblastoma in mouse model
    Song, Yujie
    Liu, Qingtian
    Zuo, Tong
    Wei, Guoyan
    Jiao, Shunchang
    CELLULAR IMMUNOLOGY, 2020, 352
  • [34] Triple checkpoint blockade, but not anti-PD1 alone, enhances the efficacy of engineered adoptive T cell therapy in advanced ovarian cancer
    Anderson, Kristin G.
    Su, Yapeng
    Burnett, Madison G.
    Bates, Breanna M.
    Suarez, Magdalia L. Rodgers
    Ruskin, Susan L.
    Voillet, Valentin
    Gottardo, Raphael
    Greenberg, Philip D.
    CANCER RESEARCH, 2024, 84 (05)
  • [35] Blockade of PD-L1 in combination with adoptive T cell therapy and DC vaccination enhances survival of lymphopenic mice bearing melanoma
    Pilon-Thomas, Shari
    Vohra, Nasreen
    Mackay, Amy
    Mule, James
    CANCER RESEARCH, 2009, 69
  • [36] Triple checkpoint blockade, but not anti-PD1 alone, enhances the efficacy of engineered adoptive T cell therapy in advanced ovarian cancer
    Anderson, Kristin G.
    Su, Yapeng
    Burnett, Madison
    Bates, Breanna
    Suarez, Magdalia Rodgers
    Voillet, Valentin
    Gottardo, Raphael
    Greenberg, Philip D.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [37] Triple checkpoint blockade, but not anti-PD1 alone, enhances the efficacy of engineered adoptive T cell therapy in advanced ovarian cancer
    Anderson, Kristin G.
    Su, Yapeng
    Burnett, Madison G.
    Bates, Breanna M.
    Suarez, Magdalia L. Rodgers
    Ruskin, Susan L.
    Vakil, Aesha
    Voillet, Valentin
    Gottardo, Raphael
    Greenberg, Philip
    CANCER RESEARCH, 2022, 82 (12)
  • [38] TALIMOGENE LAHERPAREPVEC ENHANCES THE EFFICACY OF PD-1 BLOCKADE
    Ribas, A.
    Dummer, R.
    Puzanov, I
    VanderWalde, A.
    Andtbacka, R. H.
    Michielin, O.
    CANCER DISCOVERY, 2017, 7 (11) : 1211 - 1211
  • [39] Non-synergy of PD-1 blockade with T-cell therapy in solid tumors
    Davies, John S.
    Karimipour, Farrah
    Zhang, Ling
    Nagarsheth, Nisha
    Norberg, Scott
    Serna, Carylinda
    Strauss, Julius
    Chiou, Shinheng
    Gulley, James L.
    Hinrichs, Christian S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (07)
  • [40] PD-1 blockade reverts motility arrest of transferred tumor-infiltrating CD8+T cells in adoptive cell transfer immunotherapy
    Mehta, Gautam
    Sukumar, Madhuhasan
    McGavern, Dorian
    Restifo, Nicholas
    JOURNAL OF IMMUNOLOGY, 2015, 194
12345